C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
10/2002
10/10/2002	US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002	US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002	US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002	US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002	US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002	US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002	US20020146685 Kit for use in the accurate detection of viral infections
10/10/2002	US20020146420 Protein tyrosine kinase agonist antibodies
10/10/2002	US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002	US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002	CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002	CA2442363A1 Reducing the immunogenicity of fusion proteins
10/10/2002	CA2442064A1 G-protein coupled receptors
10/10/2002	CA2442062A1 Secreted proteins
10/09/2002	EP1246933A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
10/09/2002	EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002	EP1246919A1 Progenitor cell preservation factors and related methods and products
10/09/2002	EP1246917A2 Human stra6 polypeptides
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246843A1 Novel fgf homolog zfgf12
10/09/2002	EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40
10/09/2002	EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002	EP0651761B1 Method for modification of recombinant polypeptides
10/09/2002	EP0640098B1 Canine coronavirus s gene and uses therefor
10/09/2002	CN1373771A Vaccine
10/09/2002	CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/08/2002	US6462254 Detecting gene expression of fusion proteins
10/08/2002	US6461617 Recombinant toxin fragments
10/08/2002	CA2047119C Vitro processing of fusion proteins
10/03/2002	WO2002077895A2 Method for epigenetic feature selection
10/03/2002	WO2002077272A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
10/03/2002	WO2002077218A1 Coagulation factor vii derivatives
10/03/2002	WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002	WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002	WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002	WO2002077174A2 Human cytokine receptor
10/03/2002	WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002	WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002	WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002	WO2002002751A3 Alteration of cell membrane
10/03/2002	WO2001098515A3 Gene-regulating conjugates
10/03/2002	WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002	WO2001071004A3 Proteases
10/03/2002	WO2001019846A9 Transgenically produced fusion proteins
10/03/2002	US20020142960 Exposing cells to an aggregate formulation which comprises VP22, or a polypeptide with transport function of VP22, and oligonucleotides or polynucleotides; exposing cells to a disaggregating agent which can promote disaggregation
10/03/2002	US20020142444 AL-2 neurotrophic factor
10/03/2002	US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002	US20020142389 Soluble T cell receptor
10/03/2002	US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002	US20020142359 Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system
10/03/2002	US20020142000 Genetic engineering
10/03/2002	US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002	CA2442232A1 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
10/03/2002	CA2441986A1 Methods and products related to fgf dimerization
10/03/2002	CA2441706A1 A new essential downstream component of the wingless signalling pathway
10/03/2002	CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002	CA2441580A1 Coagulation factor vii derivatives
10/03/2002	CA2439961A1 Human cytokine receptor
10/03/2002	CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/02/2002	EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002	EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002	EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002	EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002	EP1244703A1 Novel abcb9 transporter and uses thereof
10/02/2002	EP1244692A2 Compositions and methods for detecting stress-inducible proteins
10/02/2002	EP1244689A2 Cytokine polypeptides and nucleic acids
10/02/2002	EP1244470A2 Use of heat shock proteins to enhance production of chemokines by a cell
10/02/2002	EP1244466A2 Activation and inhibition of the immune system
10/02/2002	CN1372642A Receptor analysis method
10/01/2002	US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002	US6458366 Compounds and methods for diagnosis of tuberculosis
10/01/2002	US6458360 Soluble complement regulatory molecules
10/01/2002	CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies
10/01/2002	CA2119930C Production of chimeric antibodies - a combinatorial approach
10/01/2002	CA2109602C Methods for producing members of specific binding pairs
10/01/2002	CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
09/2002
09/28/2002	CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
09/26/2002	WO2002074950A1 Method of analyzing intermolecular interaction
09/26/2002	WO2002074913A2 Nucleic acid-associated proteins
09/26/2002	WO2002074904A2 Rearranged squamous cell carcinoma antigen genes ii
09/26/2002	WO2002074807A2 Chimpanzee erythropoietin (chepo) - immunoadhesins
09/26/2002	WO2002074806A2 New interferon beta-like molecules
09/26/2002	WO2002074805A1 Soluble rage protein
09/26/2002	WO2002074796A2 Histidine phosphatase interacting protein with 240kd
09/26/2002	WO2002074792A1 Fo-6979 substances and process for producing the same
09/26/2002	WO2002062957A3 Ter sites and ter binding proteins
09/26/2002	WO2002040501A3 Membrane scaffold proteins
09/26/2002	WO2002038609A3 Apolipoprotein conjugates
09/26/2002	WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
09/26/2002	WO2002000710A3 B7-like molecules and uses thereof
09/26/2002	WO2001094418A3 Leader peptides for enhancing secretion of recombinant protein from a host cell
09/26/2002	WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
09/26/2002	WO2001047953A3 Antibodies against plasma cells
09/26/2002	WO2001025401A9 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins
09/26/2002	WO2001023421A9 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
09/26/2002	US20020137679 Thrombospondins-1 and -2 are adhesive glycoproteins proteins that are angiogenesis inhibitors; portions of TSP- 1, TSP-2, endostatin, angiostatin, platelet factor 4, or prolactin linked to a portion of cartilage oligoeric matrix protein
09/26/2002	US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it
09/26/2002	US20020137137 Genetic engineering; polypeptides
09/26/2002	US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same

1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 295